Guideline promotion increases prescription of bone protection with steroids in hospitalised patients
| dc.contributor.author | Harty, L | |
| dc.contributor.author | Clare, J | |
| dc.contributor.author | Finnerty, D | |
| dc.contributor.author | Van Der Kamp, S. | |
| dc.contributor.author | Kennedy, F | |
| dc.contributor.author | Callanan, I | |
| dc.contributor.author | McKenna, MJ | |
| dc.contributor.author | FitzGerald, O | |
| dc.date.accessioned | 2015-08-18T11:56:28Z | en |
| dc.date.available | 2015-08-18T11:56:28Z | en |
| dc.date.issued | 2015-07 | en |
| dc.identifier.uri | http://hdl.handle.net/10147/575046 | en |
| dc.description.abstract | Guidelines for the prevention of glucocorticoid (GC) induced osteoporosis (GIOP) were implemented in a level 5 Irish Hospital with cross sectional audit of inpatient prescribing undertaken before and after. Prior to guideline implementation, elemental calcium (Ca) with Vitamin D (VitD) was prescribed for 11/66 (17%) of patients on GCs with 2/66 (3%) also receiving bisphosphonate (BP) therapy. Subsequent to guideline implementation, Ca with VitD was prescribed for 19/55 (35%) of patients on GCs with 11/55 (20%) also receiving BP therapy, representing a 2 and 6 fold respective increase. Internal promotion of guidelines is an effective strategy for healthcare improvement but needs refinement with or without repetition to achieve better patient outcomes. | |
| dc.language.iso | en | en |
| dc.publisher | Irish Medical Journal | en |
| dc.subject | OSTEOPOROSIS | en |
| dc.subject | PRESCRIBING | en |
| dc.title | Guideline promotion increases prescription of bone protection with steroids in hospitalised patients | en |
| dc.type | Article | en |
| dc.identifier.journal | Irish medical journal | en |
| dc.description.funding | No funding | en |
| dc.description.province | Leinster | en |
| dc.description.peer-review | peer-review | en |
| refterms.dateFOA | 2018-08-27T05:29:51Z | |
| html.description.abstract | Guidelines for the prevention of glucocorticoid (GC) induced osteoporosis (GIOP) were implemented in a level 5 Irish Hospital with cross sectional audit of inpatient prescribing undertaken before and after. Prior to guideline implementation, elemental calcium (Ca) with Vitamin D (VitD) was prescribed for 11/66 (17%) of patients on GCs with 2/66 (3%) also receiving bisphosphonate (BP) therapy. Subsequent to guideline implementation, Ca with VitD was prescribed for 19/55 (35%) of patients on GCs with 11/55 (20%) also receiving BP therapy, representing a 2 and 6 fold respective increase. Internal promotion of guidelines is an effective strategy for healthcare improvement but needs refinement with or without repetition to achieve better patient outcomes. |
